

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.66146095 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.66146095 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.54963723 |
| 4 | detection of other organism (GO:0098543) | 4.25325346 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.21131493 |
| 6 | detection of bacterium (GO:0016045) | 4.19438564 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.16941740 |
| 8 | NIK/NF-kappaB signaling (GO:0038061) | 3.98802781 |
| 9 | desmosome organization (GO:0002934) | 3.84463539 |
| 10 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.83836063 |
| 11 | negative thymic T cell selection (GO:0045060) | 3.73698587 |
| 12 | negative T cell selection (GO:0043383) | 3.67374804 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.65773989 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 3.55692421 |
| 15 | hemidesmosome assembly (GO:0031581) | 3.52962594 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 3.50753641 |
| 17 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.49379812 |
| 18 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.48339315 |
| 19 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.44003735 |
| 20 | thymic T cell selection (GO:0045061) | 3.41520529 |
| 21 | detection of external biotic stimulus (GO:0098581) | 3.41119638 |
| 22 | response to type I interferon (GO:0034340) | 3.40690173 |
| 23 | positive regulation of antigen processing and presentation (GO:0002579) | 3.38452866 |
| 24 | type I interferon signaling pathway (GO:0060337) | 3.36834866 |
| 25 | cellular response to type I interferon (GO:0071357) | 3.36834866 |
| 26 | growth hormone receptor signaling pathway (GO:0060396) | 3.34719682 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 3.34349126 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.33281223 |
| 29 | regulation of T cell tolerance induction (GO:0002664) | 3.30838569 |
| 30 | B cell receptor signaling pathway (GO:0050853) | 3.28725976 |
| 31 | response to peptidoglycan (GO:0032494) | 3.25663012 |
| 32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.24855854 |
| 33 | positive regulation of interferon-alpha production (GO:0032727) | 3.23779881 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.21492081 |
| 35 | cellular extravasation (GO:0045123) | 3.15070457 |
| 36 | B cell mediated immunity (GO:0019724) | 3.12686151 |
| 37 | hepatocyte apoptotic process (GO:0097284) | 3.12224231 |
| 38 | T cell selection (GO:0045058) | 3.12221690 |
| 39 | regulation of hypersensitivity (GO:0002883) | 3.11210560 |
| 40 | positive regulation of B cell differentiation (GO:0045579) | 3.08209288 |
| 41 | myeloid dendritic cell differentiation (GO:0043011) | 3.07695673 |
| 42 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00716523 |
| 43 | regulation of water loss via skin (GO:0033561) | 3.00347462 |
| 44 | interferon-gamma secretion (GO:0072643) | 3.00214809 |
| 45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99148636 |
| 46 | regulation of natural killer cell differentiation (GO:0032823) | 2.97204084 |
| 47 | myeloid dendritic cell activation (GO:0001773) | 2.96009904 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 2.95833693 |
| 49 | histone H3-K36 demethylation (GO:0070544) | 2.95688558 |
| 50 | establishment of skin barrier (GO:0061436) | 2.95116025 |
| 51 | detection of biotic stimulus (GO:0009595) | 2.91951331 |
| 52 | regulation of antigen processing and presentation (GO:0002577) | 2.91276737 |
| 53 | T cell migration (GO:0072678) | 2.88927150 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.88099828 |
| 55 | detection of molecule of bacterial origin (GO:0032490) | 2.88021847 |
| 56 | response to muramyl dipeptide (GO:0032495) | 2.88006147 |
| 57 | positive regulation of humoral immune response (GO:0002922) | 2.86054269 |
| 58 | neutrophil activation involved in immune response (GO:0002283) | 2.79643952 |
| 59 | regulation of B cell differentiation (GO:0045577) | 2.79429105 |
| 60 | cellular response to growth hormone stimulus (GO:0071378) | 2.79048828 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.78600932 |
| 62 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78061035 |
| 63 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.77300680 |
| 64 | tolerance induction (GO:0002507) | 2.77049625 |
| 65 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.74986751 |
| 66 | molting cycle (GO:0042303) | 2.74845420 |
| 67 | hair cycle (GO:0042633) | 2.74845420 |
| 68 | T-helper cell differentiation (GO:0042093) | 2.74394183 |
| 69 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.74394183 |
| 70 | phospholipid efflux (GO:0033700) | 2.73884216 |
| 71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73155974 |
| 72 | leukocyte aggregation (GO:0070486) | 2.72646416 |
| 73 | response to host immune response (GO:0052572) | 2.72490681 |
| 74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.72490681 |
| 75 | germinal center formation (GO:0002467) | 2.71842880 |
| 76 | regulation of response to interferon-gamma (GO:0060330) | 2.71403213 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 2.71171097 |
| 78 | regulation of RIG-I signaling pathway (GO:0039535) | 2.69923664 |
| 79 | dendritic cell chemotaxis (GO:0002407) | 2.69576093 |
| 80 | response to host (GO:0075136) | 2.68804507 |
| 81 | response to host defenses (GO:0052200) | 2.68804507 |
| 82 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68804507 |
| 83 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.68467208 |
| 84 | cellular response to interleukin-15 (GO:0071350) | 2.68141620 |
| 85 | response to interleukin-15 (GO:0070672) | 2.67679689 |
| 86 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.66996364 |
| 87 | dendritic cell migration (GO:0036336) | 2.65494279 |
| 88 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.65162557 |
| 89 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.65096743 |
| 90 | natural killer cell mediated immunity (GO:0002228) | 2.65096743 |
| 91 | interferon-gamma production (GO:0032609) | 2.63038354 |
| 92 | positive T cell selection (GO:0043368) | 2.62506511 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.62305714 |
| 94 | myeloid cell activation involved in immune response (GO:0002275) | 2.60357971 |
| 95 | membrane raft organization (GO:0031579) | 2.59863433 |
| 96 | B cell homeostasis (GO:0001782) | 2.59552348 |
| 97 | positive regulation of interleukin-2 production (GO:0032743) | 2.59403532 |
| 98 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.57130151 |
| 99 | negative regulation of cell killing (GO:0031342) | 2.57130151 |
| 100 | neutrophil activation (GO:0042119) | 2.56794423 |
| 101 | hypotonic response (GO:0006971) | 2.56720896 |
| 102 | T cell costimulation (GO:0031295) | 2.55816861 |
| 103 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.55604685 |
| 104 | positive regulation of interleukin-12 production (GO:0032735) | 2.55324864 |
| 105 | dendritic cell differentiation (GO:0097028) | 2.55071571 |
| 106 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.54122689 |
| 107 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.54110460 |
| 108 | microglial cell activation (GO:0001774) | 2.52828220 |
| 109 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.51910008 |
| 110 | lymphocyte costimulation (GO:0031294) | 2.50972422 |
| 111 | keratinization (GO:0031424) | 2.50680867 |
| 112 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.50622541 |
| 113 | cytokine secretion (GO:0050663) | 2.48976756 |
| 114 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.48771423 |
| 115 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.48448286 |
| 116 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.48448286 |
| 117 | modulation by symbiont of host immune response (GO:0052553) | 2.48448286 |
| 118 | positive regulation by symbiont of host defense response (GO:0052509) | 2.48448286 |
| 119 | modulation by symbiont of host defense response (GO:0052031) | 2.48448286 |
| 120 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.48448286 |
| 121 | defense response to protozoan (GO:0042832) | 2.47943802 |
| 122 | production of molecular mediator of immune response (GO:0002440) | 2.47936490 |
| 123 | granulocyte activation (GO:0036230) | 2.47833336 |
| 124 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.47230807 |
| 125 | positive regulation of cholesterol efflux (GO:0010875) | 2.46731217 |
| 126 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.45676745 |
| 127 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.44202489 |
| 128 | regulation of necroptotic process (GO:0060544) | 2.43825549 |
| 129 | regulation of tolerance induction (GO:0002643) | 2.43100933 |
| 130 | regulation of cholesterol storage (GO:0010885) | 2.40534191 |
| 131 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.39290730 |
| 132 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.38071200 |
| 133 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.38071200 |
| 134 | T cell differentiation involved in immune response (GO:0002292) | 2.38071200 |
| 135 | positive regulation of sterol transport (GO:0032373) | 2.36674317 |
| 136 | positive regulation of cholesterol transport (GO:0032376) | 2.36674317 |
| 137 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.36242899 |
| 138 | keratinocyte differentiation (GO:0030216) | 2.35747054 |
| 139 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.33582067 |
| 140 | T-helper 1 type immune response (GO:0042088) | 2.32662334 |
| 141 | regulation of interleukin-12 production (GO:0032655) | 2.31969885 |
| 142 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.31672903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.54730201 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.90544063 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.83188030 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.71869921 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.62827968 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.23707404 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.12870271 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.90270608 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.87542709 |
| 10 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.80103933 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.71934786 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.66035716 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.53017423 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.48468788 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.48271789 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.37724906 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34148311 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.31002305 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30389457 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.14952076 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.10094155 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.09596707 |
| 23 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.03259654 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96500694 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91074266 |
| 26 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.89837151 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89763309 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.88225592 |
| 29 | * MAF_26560356_Chip-Seq_TH1_Human | 1.85885573 |
| 30 | * MYB_26560356_Chip-Seq_TH2_Human | 1.79825697 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.79770199 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.76980573 |
| 33 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.68026513 |
| 34 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62459567 |
| 35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.55268670 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.55015592 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.53866070 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52491859 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50166678 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46533876 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45241194 |
| 42 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.45197060 |
| 43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.45197060 |
| 44 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.41833420 |
| 45 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40761147 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.40079633 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39320651 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.36627043 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32696550 |
| 50 | * MYC_22102868_ChIP-Seq_BL_Human | 1.32470937 |
| 51 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.31377982 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31198912 |
| 53 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30758912 |
| 54 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.29153046 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28760749 |
| 56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.26072197 |
| 57 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25639965 |
| 58 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24197872 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23251988 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23118964 |
| 61 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.22151152 |
| 62 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21509433 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20616114 |
| 64 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.20071108 |
| 65 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19774865 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19258626 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18940790 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18362012 |
| 69 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.18236571 |
| 70 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17609577 |
| 71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17067876 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16600121 |
| 73 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16036949 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15646104 |
| 75 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14346912 |
| 76 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.13271326 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13007876 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12826264 |
| 79 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12800186 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12023318 |
| 81 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11816403 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11717785 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11594729 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09656461 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09145097 |
| 86 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.08773815 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08211043 |
| 88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07342585 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 1.06997062 |
| 90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05629669 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05599417 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04789136 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04156077 |
| 94 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03201252 |
| 95 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03045291 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02604637 |
| 97 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01806439 |
| 98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99621913 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99135655 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98638572 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98310385 |
| 102 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97701292 |
| 103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97063018 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96456103 |
| 105 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94120727 |
| 106 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93802085 |
| 107 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93595507 |
| 108 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.93096529 |
| 109 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92123961 |
| 110 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92068598 |
| 111 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.90777858 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90623923 |
| 113 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.89586494 |
| 114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87620342 |
| 115 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87422304 |
| 116 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86566802 |
| 117 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85974242 |
| 118 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.85962886 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85777854 |
| 120 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85328677 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83337086 |
| 122 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83275780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 3.56558718 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.00905168 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 2.82809934 |
| 4 | MP0000685_abnormal_immune_system | 2.82299008 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 2.63434814 |
| 6 | MP0004947_skin_inflammation | 2.61181854 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.60163074 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.48740331 |
| 9 | MP0002796_impaired_skin_barrier | 2.48330553 |
| 10 | MP0003436_decreased_susceptibility_to | 2.47898258 |
| 11 | MP0001790_abnormal_immune_system | 2.40993789 |
| 12 | MP0005387_immune_system_phenotype | 2.40993789 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.32998582 |
| 14 | MP0005671_abnormal_response_to | 2.16314755 |
| 15 | MP0009785_altered_susceptibility_to | 2.15123960 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.13248563 |
| 17 | MP0001800_abnormal_humoral_immune | 2.12248906 |
| 18 | MP0004510_myositis | 2.09203064 |
| 19 | MP0003453_abnormal_keratinocyte_physiol | 2.08482819 |
| 20 | MP0001873_stomach_inflammation | 2.05645448 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.01169751 |
| 22 | MP0003303_peritoneal_inflammation | 2.00684876 |
| 23 | MP0002006_tumorigenesis | 1.91718488 |
| 24 | MP0005360_urolithiasis | 1.90830026 |
| 25 | MP0005025_abnormal_response_to | 1.89018499 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.88424291 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.83730143 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.83586481 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.83550413 |
| 30 | MP0006082_CNS_inflammation | 1.80993887 |
| 31 | MP0002723_abnormal_immune_serum | 1.78301222 |
| 32 | MP0005275_abnormal_skin_tensile | 1.76056687 |
| 33 | MP0001216_abnormal_epidermal_layer | 1.72956839 |
| 34 | MP0004264_abnormal_extraembryonic_tissu | 1.68596268 |
| 35 | MP0005310_abnormal_salivary_gland | 1.66626268 |
| 36 | MP0010352_gastrointestinal_tract_polyps | 1.64883805 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.63396310 |
| 38 | MP0001819_abnormal_immune_cell | 1.63231926 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.62008033 |
| 40 | MP0002419_abnormal_innate_immunity | 1.59176705 |
| 41 | MP0009840_abnormal_foam_cell | 1.57898374 |
| 42 | MP0005501_abnormal_skin_physiology | 1.57121009 |
| 43 | MP0000579_abnormal_nail_morphology | 1.56702415 |
| 44 | MP0001853_heart_inflammation | 1.56364706 |
| 45 | MP0000383_abnormal_hair_follicle | 1.54306563 |
| 46 | MP0010678_abnormal_skin_adnexa | 1.53390248 |
| 47 | MP0002060_abnormal_skin_morphology | 1.49785198 |
| 48 | MP0003724_increased_susceptibility_to | 1.49620450 |
| 49 | MP0008260_abnormal_autophagy | 1.49268819 |
| 50 | MP0002098_abnormal_vibrissa_morphology | 1.47011142 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.44801995 |
| 52 | MP0002139_abnormal_hepatobiliary_system | 1.44619059 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.44167587 |
| 54 | MP0002405_respiratory_system_inflammati | 1.44112600 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.37733880 |
| 56 | MP0004381_abnormal_hair_follicle | 1.34227663 |
| 57 | MP0000377_abnormal_hair_follicle | 1.31948008 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.31502280 |
| 59 | MP0003828_pulmonary_edema | 1.31065827 |
| 60 | MP0002009_preneoplasia | 1.28079030 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.26052663 |
| 62 | MP0000716_abnormal_immune_system | 1.24745472 |
| 63 | MP0001346_abnormal_lacrimal_gland | 1.23381706 |
| 64 | MP0002398_abnormal_bone_marrow | 1.22376661 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 1.19766478 |
| 66 | MP0005085_abnormal_gallbladder_physiolo | 1.19638895 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.17555868 |
| 68 | MP0005451_abnormal_body_composition | 1.16444903 |
| 69 | MP0003448_altered_tumor_morphology | 1.15633366 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.13755126 |
| 71 | MP0003866_abnormal_defecation | 1.13338573 |
| 72 | MP0005023_abnormal_wound_healing | 1.12854951 |
| 73 | MP0008469_abnormal_protein_level | 1.12590661 |
| 74 | MP0009764_decreased_sensitivity_to | 1.12422284 |
| 75 | MP0005365_abnormal_bile_salt | 1.11112093 |
| 76 | MP0003252_abnormal_bile_duct | 1.09802536 |
| 77 | MP0001881_abnormal_mammary_gland | 1.09089940 |
| 78 | MP0002933_joint_inflammation | 1.08458516 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 1.07138207 |
| 80 | MP0000427_abnormal_hair_cycle | 1.06960770 |
| 81 | MP0001851_eye_inflammation | 1.05824637 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 1.05347859 |
| 83 | MP0008057_abnormal_DNA_replication | 1.03546427 |
| 84 | MP0000609_abnormal_liver_physiology | 1.02151726 |
| 85 | MP0000858_altered_metastatic_potential | 1.01945295 |
| 86 | MP0001243_abnormal_dermal_layer | 1.01390081 |
| 87 | MP0002722_abnormal_immune_system | 1.00503359 |
| 88 | MP0001191_abnormal_skin_condition | 0.99101202 |
| 89 | MP0005409_darkened_coat_color | 0.97202793 |
| 90 | MP0000689_abnormal_spleen_morphology | 0.95359363 |
| 91 | MP0002429_abnormal_blood_cell | 0.95203895 |
| 92 | MP0001666_abnormal_nutrient_absorption | 0.94305029 |
| 93 | MP0001545_abnormal_hematopoietic_system | 0.94110647 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 0.94110647 |
| 95 | MP0009931_abnormal_skin_appearance | 0.92321240 |
| 96 | MP0000604_amyloidosis | 0.90802733 |
| 97 | MP0000647_abnormal_sebaceous_gland | 0.90622521 |
| 98 | MP0000627_abnormal_mammary_gland | 0.90376718 |
| 99 | MP0010771_integument_phenotype | 0.90349098 |
| 100 | MP0003941_abnormal_skin_development | 0.90329147 |
| 101 | MP0001348_abnormal_lacrimal_gland | 0.90209524 |
| 102 | MP0004883_abnormal_blood_vessel | 0.87969674 |
| 103 | MP0003045_fibrosis | 0.87874282 |
| 104 | MP0000569_abnormal_digit_pigmentation | 0.85555697 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.83748732 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83653726 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.83454291 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.83446971 |
| 109 | MP0005075_abnormal_melanosome_morpholog | 0.82076585 |
| 110 | MP0005164_abnormal_response_to | 0.81423475 |
| 111 | MP0003091_abnormal_cell_migration | 0.80536092 |
| 112 | MP0000367_abnormal_coat/_hair | 0.80024582 |
| 113 | MP0005166_decreased_susceptibility_to | 0.80001640 |
| 114 | MP0009763_increased_sensitivity_to | 0.79260578 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.79031005 |
| 116 | MP0009115_abnormal_fat_cell | 0.78899360 |
| 117 | MP0009278_abnormal_bone_marrow | 0.78605075 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.78329383 |
| 119 | MP0008961_abnormal_basal_metabolism | 0.78128356 |
| 120 | MP0010329_abnormal_lipoprotein_level | 0.77660474 |
| 121 | MP0000490_abnormal_crypts_of | 0.75316158 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.72422687 |
| 123 | MP0000249_abnormal_blood_vessel | 0.68960311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.76012912 |
| 2 | Increased IgE level (HP:0003212) | 4.35257676 |
| 3 | Myocardial infarction (HP:0001658) | 3.55811294 |
| 4 | Myositis (HP:0100614) | 3.36290769 |
| 5 | Pustule (HP:0200039) | 3.35549763 |
| 6 | Milia (HP:0001056) | 3.34423969 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.33633787 |
| 8 | Thick nail (HP:0001805) | 3.33276319 |
| 9 | Plantar hyperkeratosis (HP:0007556) | 3.32269787 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.31693898 |
| 11 | Orchitis (HP:0100796) | 3.21998427 |
| 12 | Nasal polyposis (HP:0100582) | 3.15924503 |
| 13 | Chronic otitis media (HP:0000389) | 3.12054633 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.09719380 |
| 15 | Right ventricular cardiomyopathy (HP:0011663) | 3.03745220 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 2.98163762 |
| 17 | Onycholysis (HP:0001806) | 2.95233636 |
| 18 | Recurrent abscess formation (HP:0002722) | 2.94623540 |
| 19 | Woolly hair (HP:0002224) | 2.91728902 |
| 20 | Recurrent viral infections (HP:0004429) | 2.89896506 |
| 21 | Optic neuritis (HP:0100653) | 2.85722740 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 2.85722740 |
| 23 | Pili torti (HP:0003777) | 2.84823678 |
| 24 | Abnormality of T cell number (HP:0011839) | 2.82354523 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.81577855 |
| 26 | Periodontitis (HP:0000704) | 2.79992495 |
| 27 | Vasculitis (HP:0002633) | 2.79805903 |
| 28 | Gangrene (HP:0100758) | 2.78632540 |
| 29 | Abnormality of the axillary hair (HP:0100134) | 2.76558095 |
| 30 | Abnormality of secondary sexual hair (HP:0009888) | 2.76558095 |
| 31 | Palmoplantar hyperkeratosis (HP:0000972) | 2.76184430 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 2.72958604 |
| 33 | T lymphocytopenia (HP:0005403) | 2.71467644 |
| 34 | Fragile nails (HP:0001808) | 2.68125971 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 2.67932588 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65752523 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65752523 |
| 38 | Malnutrition (HP:0004395) | 2.64190632 |
| 39 | Arterial thrombosis (HP:0004420) | 2.63206670 |
| 40 | Gingival bleeding (HP:0000225) | 2.59731436 |
| 41 | Hypergammaglobulinemia (HP:0010702) | 2.58634900 |
| 42 | Recurrent skin infections (HP:0001581) | 2.57011032 |
| 43 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.56719089 |
| 44 | Osteolytic defects of the hand bones (HP:0009699) | 2.56719089 |
| 45 | Abnormality of nail color (HP:0100643) | 2.55877142 |
| 46 | Esophageal varix (HP:0002040) | 2.55736564 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 2.55658953 |
| 48 | Palmar hyperkeratosis (HP:0010765) | 2.55380156 |
| 49 | Cellulitis (HP:0100658) | 2.53594114 |
| 50 | Stomatitis (HP:0010280) | 2.52095476 |
| 51 | Recurrent bronchitis (HP:0002837) | 2.50036525 |
| 52 | Alopecia of scalp (HP:0002293) | 2.47767766 |
| 53 | Erythema (HP:0010783) | 2.43393035 |
| 54 | Papilloma (HP:0012740) | 2.42876813 |
| 55 | Verrucae (HP:0200043) | 2.42876813 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.42858105 |
| 57 | Osteomyelitis (HP:0002754) | 2.41979083 |
| 58 | Chronic diarrhea (HP:0002028) | 2.40722973 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.40139564 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.38891304 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.38068501 |
| 62 | Hypotrichosis (HP:0001006) | 2.38001490 |
| 63 | Xanthomatosis (HP:0000991) | 2.36128360 |
| 64 | Gastrointestinal stroma tumor (HP:0100723) | 2.35993863 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.35617789 |
| 66 | Gingivitis (HP:0000230) | 2.35498934 |
| 67 | Xerostomia (HP:0000217) | 2.34101379 |
| 68 | Abnormality of T cells (HP:0002843) | 2.33802540 |
| 69 | Deep venous thrombosis (HP:0002625) | 2.32219258 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.31313474 |
| 71 | Abnormal hair laboratory examination (HP:0003328) | 2.30754534 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.30750939 |
| 73 | Skin ulcer (HP:0200042) | 2.28018142 |
| 74 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.26962316 |
| 75 | Nail dystrophy (HP:0008404) | 2.26768618 |
| 76 | Colitis (HP:0002583) | 2.26231325 |
| 77 | Hematochezia (HP:0002573) | 2.24938418 |
| 78 | Increased IgM level (HP:0003496) | 2.24120829 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 2.22509527 |
| 80 | Lip pit (HP:0100267) | 2.21781761 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.20566234 |
| 82 | Systemic lupus erythematosus (HP:0002725) | 2.19557684 |
| 83 | Cheilitis (HP:0100825) | 2.19467153 |
| 84 | Chest pain (HP:0100749) | 2.16441132 |
| 85 | Encephalitis (HP:0002383) | 2.14832894 |
| 86 | Peritonitis (HP:0002586) | 2.11782090 |
| 87 | Sparse scalp hair (HP:0002209) | 2.11404553 |
| 88 | Abnormality of T cell physiology (HP:0011840) | 2.11186398 |
| 89 | Joint swelling (HP:0001386) | 2.08742719 |
| 90 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08277870 |
| 91 | Hemoptysis (HP:0002105) | 2.07811206 |
| 92 | Abnormal blistering of the skin (HP:0008066) | 2.04728052 |
| 93 | Prostate neoplasm (HP:0100787) | 2.04025071 |
| 94 | Urticaria (HP:0001025) | 2.03523665 |
| 95 | Granulocytopenia (HP:0001913) | 2.02763405 |
| 96 | Abnormality of the prostate (HP:0008775) | 2.01684478 |
| 97 | Eosinophilia (HP:0001880) | 2.01435045 |
| 98 | Abnormality of the gastric mucosa (HP:0004295) | 2.00791803 |
| 99 | Panhypogammaglobulinemia (HP:0003139) | 2.00682456 |
| 100 | Flat acetabular roof (HP:0003180) | 2.00409584 |
| 101 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00282653 |
| 102 | Atrophic scars (HP:0001075) | 1.98738082 |
| 103 | Ridged nail (HP:0001807) | 1.97957113 |
| 104 | Anorexia (HP:0002039) | 1.97693442 |
| 105 | Subacute progressive viral hepatitis (HP:0006572) | 1.97130365 |
| 106 | Viral hepatitis (HP:0006562) | 1.96797668 |
| 107 | Leukocytosis (HP:0001974) | 1.96167717 |
| 108 | Pulmonary embolism (HP:0002204) | 1.95745892 |
| 109 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.95722746 |
| 110 | Vacuolated lymphocytes (HP:0001922) | 1.95556804 |
| 111 | Lymphopenia (HP:0001888) | 1.95271981 |
| 112 | Abnormality of the common coagulation pathway (HP:0010990) | 1.93616634 |
| 113 | Spontaneous hematomas (HP:0007420) | 1.93176450 |
| 114 | Sepsis (HP:0100806) | 1.93146716 |
| 115 | Skin rash (HP:0000988) | 1.92418228 |
| 116 | Premature loss of primary teeth (HP:0006323) | 1.91969627 |
| 117 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.91643685 |
| 118 | Intrahepatic cholestasis (HP:0001406) | 1.90395487 |
| 119 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89362655 |
| 120 | Obstructive lung disease (HP:0006536) | 1.89362655 |
| 121 | Meningitis (HP:0001287) | 1.88677915 |
| 122 | IgA deficiency (HP:0002720) | 1.88099335 |
| 123 | Complement deficiency (HP:0004431) | 1.87862234 |
| 124 | Pruritus (HP:0000989) | 1.87857235 |
| 125 | Nephritis (HP:0000123) | 1.87257881 |
| 126 | Emphysema (HP:0002097) | 1.86935417 |
| 127 | Abnormality of complement system (HP:0005339) | 1.86534897 |
| 128 | Abnormality of the fingertips (HP:0001211) | 1.84972243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.58055102 |
| 2 | TYK2 | 3.29883959 |
| 3 | MAP4K1 | 3.19290984 |
| 4 | FGFR4 | 3.01359424 |
| 5 | JAK3 | 2.72231652 |
| 6 | TBK1 | 2.62460956 |
| 7 | PRPF4B | 2.58163922 |
| 8 | IKBKE | 2.54136254 |
| 9 | ERN1 | 2.48504146 |
| 10 | MST4 | 2.46747611 |
| 11 | JAK1 | 2.38600749 |
| 12 | TXK | 2.35078798 |
| 13 | EPHB1 | 2.19950468 |
| 14 | STK10 | 2.16928744 |
| 15 | IKBKB | 1.98052503 |
| 16 | EPHA3 | 1.94912273 |
| 17 | FGFR3 | 1.78452549 |
| 18 | SIK1 | 1.71520609 |
| 19 | CHUK | 1.70878543 |
| 20 | BMPR2 | 1.70590475 |
| 21 | TRIB3 | 1.65470727 |
| 22 | ITK | 1.59529895 |
| 23 | PTK6 | 1.54050919 |
| 24 | TNK2 | 1.53836000 |
| 25 | MAP3K13 | 1.51323961 |
| 26 | ZAP70 | 1.50381526 |
| 27 | BLK | 1.46999725 |
| 28 | NLK | 1.44364156 |
| 29 | LRRK2 | 1.43315880 |
| 30 | TTN | 1.39991750 |
| 31 | MST1R | 1.37277230 |
| 32 | CSK | 1.35957448 |
| 33 | IRAK4 | 1.30877668 |
| 34 | MAP3K3 | 1.29341017 |
| 35 | TAOK3 | 1.29250164 |
| 36 | MAP3K10 | 1.27487050 |
| 37 | RIPK1 | 1.26508136 |
| 38 | CDK12 | 1.25613365 |
| 39 | SIK3 | 1.24070636 |
| 40 | JAK2 | 1.22749234 |
| 41 | EPHA2 | 1.20502314 |
| 42 | RPS6KA4 | 1.18253479 |
| 43 | SMG1 | 1.16715120 |
| 44 | LATS1 | 1.15136764 |
| 45 | PIM2 | 1.14414541 |
| 46 | IRAK3 | 1.13669228 |
| 47 | GRK6 | 1.11679089 |
| 48 | NEK9 | 1.11279818 |
| 49 | PKN2 | 1.10338986 |
| 50 | KIT | 1.06778196 |
| 51 | CDC42BPA | 1.05470763 |
| 52 | HCK | 1.03974017 |
| 53 | LCK | 1.02839747 |
| 54 | BTK | 1.01044778 |
| 55 | TRPM7 | 0.96705061 |
| 56 | TGFBR2 | 0.92970136 |
| 57 | EEF2K | 0.92781415 |
| 58 | MARK2 | 0.92708052 |
| 59 | FES | 0.92302636 |
| 60 | CDK6 | 0.92022640 |
| 61 | PIM1 | 0.91703673 |
| 62 | FRK | 0.91568269 |
| 63 | STK24 | 0.89344759 |
| 64 | MAP3K2 | 0.87070741 |
| 65 | SYK | 0.86498245 |
| 66 | STK3 | 0.83910843 |
| 67 | MELK | 0.82739279 |
| 68 | MATK | 0.81222980 |
| 69 | IRAK1 | 0.80102008 |
| 70 | CAMK1G | 0.78545157 |
| 71 | BMX | 0.77377656 |
| 72 | MAP3K9 | 0.75564163 |
| 73 | PDK1 | 0.73685378 |
| 74 | CSF1R | 0.70738937 |
| 75 | KSR2 | 0.70378760 |
| 76 | SGK3 | 0.69004027 |
| 77 | MAP3K7 | 0.68944080 |
| 78 | PRKCQ | 0.68813761 |
| 79 | NUAK1 | 0.68147971 |
| 80 | DYRK1B | 0.68075753 |
| 81 | TEC | 0.67671630 |
| 82 | MARK3 | 0.66128992 |
| 83 | FER | 0.65935172 |
| 84 | PRKD2 | 0.65083012 |
| 85 | IRAK2 | 0.63206555 |
| 86 | WNK1 | 0.62271100 |
| 87 | ARAF | 0.62224961 |
| 88 | EPHB2 | 0.61387156 |
| 89 | PDPK1 | 0.61211730 |
| 90 | MAPK11 | 0.60804514 |
| 91 | NEK6 | 0.59132328 |
| 92 | PTK2 | 0.58680677 |
| 93 | MAPK7 | 0.57819189 |
| 94 | YES1 | 0.57574722 |
| 95 | ACVR1B | 0.57299124 |
| 96 | MAP2K3 | 0.56852272 |
| 97 | MAP3K6 | 0.56605052 |
| 98 | RIPK4 | 0.55535128 |
| 99 | NME2 | 0.54074636 |
| 100 | TESK2 | 0.52212945 |
| 101 | ABL1 | 0.52066409 |
| 102 | MAPKAPK2 | 0.51973242 |
| 103 | HIPK2 | 0.51846420 |
| 104 | BRD4 | 0.51359187 |
| 105 | CAMK1D | 0.51302403 |
| 106 | MAPKAPK3 | 0.51297765 |
| 107 | MOS | 0.49902356 |
| 108 | SGK2 | 0.49517018 |
| 109 | PIK3CA | 0.47914942 |
| 110 | TGFBR1 | 0.47594184 |
| 111 | PRKAA2 | 0.46388715 |
| 112 | TESK1 | 0.45934561 |
| 113 | EGFR | 0.45918872 |
| 114 | CDK4 | 0.45851008 |
| 115 | RPS6KA1 | 0.45623212 |
| 116 | KDR | 0.44450005 |
| 117 | PDGFRB | 0.44212076 |
| 118 | MAP3K1 | 0.44022915 |
| 119 | PIK3CG | 0.42280184 |
| 120 | FLT3 | 0.41669017 |
| 121 | MAP3K8 | 0.41379678 |
| 122 | FGFR1 | 0.41169350 |
| 123 | STK4 | 0.40429668 |
| 124 | LYN | 0.40039300 |
| 125 | MAP2K2 | 0.40035896 |
| 126 | DMPK | 0.39774893 |
| 127 | CDK9 | 0.39310115 |
| 128 | GSK3A | 0.36496927 |
| 129 | RPS6KB2 | 0.33478882 |
| 130 | RET | 0.32470201 |
| 131 | TAOK1 | 0.31709958 |
| 132 | MAP3K11 | 0.31403223 |
| 133 | FGR | 0.30914067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.59462084 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.50943249 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39096662 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.37154908 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.30185134 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.29670630 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19460169 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.11250493 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.06089585 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89672630 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89638572 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.89397580 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.88164283 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.82807993 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80659711 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73832743 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69481233 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63751456 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63548072 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58092212 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.52258845 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.49125904 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.48322757 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.46894914 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.36853033 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.36032428 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.33291545 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32622593 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.31894033 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.30726111 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29791408 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.29182782 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27703275 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24005033 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.23568898 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23551032 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.23255919 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.23057010 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19652806 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19391841 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18302298 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18139323 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.14583086 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10941940 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04104427 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02886662 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.00477840 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00463681 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99755994 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.99534001 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94992474 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94677496 |
| 53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94327054 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93719972 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92949056 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92491099 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88569536 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87954169 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.87812432 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.87063287 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.86397832 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.86315931 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85959169 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85380407 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85247184 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82920011 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.82720796 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.81953915 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81217396 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.79260582 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78580570 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76486806 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76300877 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75843030 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75513437 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.75426860 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72921384 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68493195 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67257312 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64402820 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63952341 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63846667 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63682334 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63334874 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63285759 |
| 86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63033946 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61871419 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59075679 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58873365 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58466254 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58363131 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57477019 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56269133 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55669533 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.54032627 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53912474 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52352342 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.50832089 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50478586 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.50163928 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49121947 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47273904 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46463935 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46339941 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44844718 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44361910 |
| 107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43690974 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43461414 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43385515 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43022461 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40410083 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40334360 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39784246 |
| 114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39769909 |
| 115 | Bile secretion_Homo sapiens_hsa04976 | 0.39680001 |
| 116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39585097 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.39499271 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.39317969 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38794954 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38237750 |
| 121 | Focal adhesion_Homo sapiens_hsa04510 | 0.36927303 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35916900 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.35231045 |
| 124 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34957829 |
| 125 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32971846 |
| 126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32557691 |
| 127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32396272 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32011796 |

